A 74-year-old woman with several oscillating intracardiac masses on the aortic valve was admitted for fever and subacute brain infarction suggestive of infectious endocarditis( IE). After empirical antibiotic treatment for four weeks according to the guidelines for IE, cardiac masses remained on the valve; however, blood culture tests were negative. These findings did not support our initial diagnosis of IE, and, in fact, suggested that IE was unlikely. The patient underwent tumor resection under cardiopulmonary bypass to prevent repeat embolism and obtain definitive diagnosis. Intraoperatively, oscillating masses appeared to be primary cardiac tumors, and were resected from the non-coronary cusp and the commissure between the right and non-coronary cusp. Pathological diagnosis was papillary fibroelastoma, and currently, the patient is free from recurrence.
Download full-text PDF |
Source |
---|
Eur Heart J Case Rep
January 2025
The Second Department of Internal Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.
Background: Self-expanding valves used in transcatheter aortic valve implantation (TAVI) are designed to allow recapture and repositioning, facilitating optimal placement and mitigating conduction disturbances and paravalvular leakage. Here, we present a rare case in which the Navitor (Abbott Structural Heart, Santa Clara, CA, USA) could not be recaptured.
Case Summary: An 81-year-old Japanese woman with very severe aortic stenosis and a massively calcified nodule at the non-coronary cusp (NCC) underwent TAVI with a 25 mm Navitor valve.
Medicina (Kaunas)
January 2025
Department of Cardiology, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Lithuanian University of Health Sciences, 2 Eivenių Str., LT-50009 Kaunas, Lithuania.
: Transcatheter aortic valve implantation (TAVI) has emerged as a pivotal intervention for managing severe aortic stenosis in high-risk surgical patients. : This study aimed to evaluate the impacts of procedural factors and patient characteristics on TAVI outcomes, with a focus on survival rates, cardiac mortality, and associated complications. : A retrospective, single-center study involving 224 patients who underwent TAVI at the Lithuanian University of Health Sciences from September 2021 to April 2023 was conducted.
View Article and Find Full Text PDFEur Heart J Case Rep
January 2025
Department of Cardiovascular Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
Background: Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for patients with severe aortic valve stenosis; however, clinical valve thrombosis is a major challenge.
Case Summary: A 92-year-old woman underwent TAVR for severe aortic stenosis. One month later, the patient developed acute heart failure.
Cureus
November 2024
Cardiovascular Surgery, Sapporo Medical University, Sapporo, JPN.
The patient an 85-year-old female resided in a care facility where she maintained an independent daily activity level. She was discovered hunched over a table in her room, displaying reduced responsiveness and prompting an emergency call. Initially, her blood pressure was within 60 mmHg, and she was transported by ambulance to our hospital.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
January 2025
Cardiovascular Department, Jolimont Hospital, La Louvière, Belgium.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!